Journal of
Microbiology and Antimicrobials

  • Abbreviation: J. Microbiol. Antimicrob.
  • Language: English
  • ISSN: 2141-2308
  • DOI: 10.5897/JMA
  • Start Year: 2009
  • Published Articles: 156

Full Length Research Paper

Prevalence and antimicrobial susceptibility of uropathogens in patients reporting to a tertiary care facility in Peshawar, Pakistan

Nasrullah Malik*
  • Nasrullah Malik*
  • CM Hospital, Peshawar, Pakistan.
  • Google Scholar
Mamoon Ahmed
  • Mamoon Ahmed
  • National University of Sciences and Technology, Islamabad, Pakistan.
  • Google Scholar
Muneeb ur Rehman
  • Muneeb ur Rehman
  • National University of Sciences and Technology, Islamabad, Pakistan.
  • Google Scholar


  •  Received: 23 July 2014
  •  Accepted: 14 January 2015
  •  Published: 31 January 2015

References

 

Arjunan M, Al-Salamah A, Amuthan M (2010). Prevalence and antibiotics susceptibility of uropathogens in patients from a rural environment, Tamilnadu. Am. J. Infect. Dis. 6(2):29.
Crossref
 
Assefa A, Asrat D, Woldeamanuel Y, Abdella A, Melesse T, Hiwot GY (2008). Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiop. Med. J. 4(3):227-235.
 
Bae E, Lee S, Jeong D, Kang J (2010). Clinical Characteristics and Antibiotic Resistance of Urinary Tract Infections in Children: Escherichia. coli Versus Non-E. coli. Korean J. Pediatr. Infect. Dis. 17(2):67-73.
 
Barber A, Norton J, Spivak A, Mulvey M (2013). Urinary tract infections: current and emerging management strategies. Clin. Infect. Dis. 57(5):719-724.
Crossref
 
Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45(4):493.
Pubmed
 
Den Heijer C, Donker G, Maes J, Stobberingh E (2013). Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients. Prevalence and resistance of the commensal flora in non-hospitalized patients. 65: 61.
 

Epoke CO, Anyanwu GO, Opara AA (2000). The prevalence of significant bacteriuria in diabetic patients. Diabetic Int. 10:16-7. B F. Epidemiology of urinary tract infections: incidence, morbidity, and... - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2014 [cited 30 December 2014]. 

View

 
Farooqi B, Shareeq F, Rizvi Q, Qureshi H, Ashfaq M (2000). Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections. J-Pak. Med. Assoc. 50(11):369-373.
Pubmed
 
Fluit A, Schmitz F, Jones M, Acar J, Gupta R, Verhoef J (1999). Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. Int. J. Infect. Dis. 3(3):153-156.
Crossref
 
Foxman B (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(1):5-13.
Crossref
 
Fridkin S, Srinivasan A (2014). Implementing a Strategy for Monitoring Inpatient Antimicrobial Use Among Hospitals in the United States. Clin. Infect. Dis. 58(3):401-406.
Crossref
 
Garcia Garcia MI, Munoz Bellido JL, García-Rodríguez JA (2007). In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004). J. Chemother. 19(3):263-270.
Crossref
 
Gonzalez C, Schaeffer A (1999). Treatment of urinary tract infection: what's old, what's new, and what works. World J. Urol. 17(6):372-382.
Crossref
 
Gul N, Mujahid T, Ahmed S (2004). Isolation, identification and antibiotic resistance profile of indigenous bacterial isolates from urinary tract infection patients. Pak. J. Biol. Sci. 7(12):2051-2054.
Crossref
 
Gupta K, Hooton T, Stamm W (2001). Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135(1):41-50.
Crossref
 
Heginbothom M, Magee J, Bell J, Dunstan F, Howard A, Hillier S, Palmer S, Mason BW, Welsh Antibiotic Study Group (2004). Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J. Antimicrob. Chemother. 53(6):1010-1017.
Crossref
 
Kahlmeter G (2003). Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO\textperiodcentered SENS study. International journal of antimicrobial agents. 22:49-52.
Crossref
 
Karlowsky J, Kelly L, Thornsberry C, Jones M, Sahm D (2002). Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46(8):2540-2545.
Crossref
 
Karlowsky J, Lagac\'E-Wiens P, Simner P, Decorby M, Adam H, Walkty A, Hoban D, Zhanel G (2011). Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob. Agents Chemother. 55(7):3169-3175.
Crossref
 
Kashef N, Djavid G, Shahbazi S (2010). Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran. J. Infect. Dev. Countr. 4(04):202-206.
 
Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF (2009). Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa state, Nigeria. Int. J. Med. Sci. 1(5):163-167.
 
Kothari A, Sagar V (2008). Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J. Infect. Dev. Count. 2(05):354-358.
 
Linhares I, Raposo T, Rodrigues A, Almeida A (2013). Frequency and antimicrobial susceptibility patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect. Dis. 13(1):19.
Crossref
 
Mazzulli T (2002). Resistance trends in urinary tract pathogens and impact on management. J. Urol. 168(4):1720-1722.
Crossref
 
Novara G (2008). Editorial Comment on: Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. Eur. Urol. 54(5):1175-1176.
Crossref
 
Rahman F, Chowdhury S, Rahman M, Ahmed D, Hossain A (2009). Antimicrobial susceptibility pattern of gram-negative bacteria causing urinary tract infection. Stamford J. Pharmaceut. Sci. 2(1):44-50.
 
Rao D, Basu R, Sarkar A, Bidyarani K (2013). Prevalence and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae Isolated From Respiratory Samples in a South Indian Tertiary Care Hospital. Int. J. Health Sci. Res. (IJHSR). 3(11):121-126.
 
Rock W, Colodner R, Chazan B, Elias M, Raz R (2007). Ten years surveillance of antimicrobial susceptibility to community-acquired Escherichla coll and other uropathogens in Northern Israel (1995-2005). Isr. Med. Assoc. J. Ramat-Gan 9(11):803.
 
Sharif SI, OHM Ibrahim, Mouslli L, Waisi R (2012). Evaluation of self-medication among pharmacy students. Am. J. Pharmacol. Toxicol. 7:135-140.
Crossref
 
Sire J, Nabeth P, Perrier-Gros-Claude J, Bahsoun I, Siby T, Macondo E, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B (2007). Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J. Infect. Dev. Count. 1(03):263-268.
 
Stamm W (2006). Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections. Transactions of the American clinical and climatological association. 117:75.
Pubmed
 
Stock I, Burak S, Sherwood KJ, Gruger T, Wiedemann B (2003). Natural antimicrobial susceptibilities of strains of unusual Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea. J. Antimicrob. Chemother. 51(4):865-885.
Crossref
 
Traub W (2000). Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens. Chemother. 46(5):315-321.
Crossref
 
Turner P (2008). Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn. Microbiol. Infect. Dis. 60(2):185-192.
Crossref
 
Ullah F, Malik S, Ahmed J (2009). Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr. J. Biotechnol. 8:16.
 
Wiles T, Kulesus R, Mulvey M (2008). Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85(1):11-19.
Crossref